Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

GSK983

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Summary Genome-wide analysis of the mode of action of GSK983, a potent antiviral agent, led to the identification of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
Abstract Specific host pathways that may be targeted therapeutically to inhibit the replication of Ebola virus (EBOV) and other… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2018
2018
Abstract Ebola virus (EBOV) is an enveloped negative‐sense, single‐stranded RNA virus of the filovirus family that causes severe… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2016
Highly Cited
2016
Broad spectrum antiviral drugs targeting host processes could potentially treat a wide range of viruses while reducing the… Expand
  • figure 1
  • figure 2
  • figure 3
2016
2016
  • D. Burgess
  • Nature Reviews Genetics
  • 2016
  • Corpus ID: 13290725
function screens in mammalian cells have progressed rapidly, particularly with RNA interference (RNAi)based libraries and, more… Expand
2009
2009
Abstract GSK983, a novel tetrahydrocarbazole, inhibits the replication of a variety of unrelated viruses in vitro with EC50… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • table 3